We are live on ! Find out more
MRCM

M&R Capital Management Portfolio holdings

AUM $454M
1-Year Est. Return 40.11%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$419M
AUM Growth
+$10.9M
Cap. Flow
+$2.31M
Cap. Flow %
0.55%
Top 10 Hldgs %
47.82%
Holding
559
New
11
Increased
126
Reduced
102
Closed
12

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$8.37M
2
CACI icon
CACI
CACI
+$5.74M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$2.32M
4
PEP icon
PepsiCo
PEP
+$1.38M
5
ACGL icon
Arch Capital
ACGL
+$1.25M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$8.98M
2
CMCSA icon
Comcast
CMCSA
+$2.47M
3
LW icon
Lamb Weston
LW
+$2.32M
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$1.3M
5
MMM icon
3M
MMM
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 27.36%
2 Financials 20.03%
3 Healthcare 10.65%
4 Communication Services 9.1%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OPK icon
401
Opko Health
OPK
$1.1B
$7.5K ﹤0.01%
6,000
– –
FWONA icon
402
Liberty Media Series A
FWONA
$23.4B
$7.45K ﹤0.01%
116
– –
AIG icon
403
American International
AIG
$40.2B
$7.42K ﹤0.01%
100
– –
PFFD icon
404
Global X US Preferred ETF
PFFD
$2.15B
$7.38K ﹤0.01%
375
– –
SDVY icon
405
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.6B
$7.34K ﹤0.01%
220
+5
+2% +$168
BR icon
406
Broadridge
BR
$20.9B
$7.29K ﹤0.01%
37
– –
BP icon
407
BP
BP
$109B
$7.22K ﹤0.01%
200
– –
ARRY icon
408
Array Technologies
ARRY
$707M
$7.18K ﹤0.01%
700
+200
+40% +$2.54K
ASML icon
409
ASML
ASML
$651B
$7.16K ﹤0.01%
7
– –
VOD icon
410
Vodafone
VOD
$37.1B
$7.1K ﹤0.01%
800
– –
GM icon
411
General Motors
GM
$75.7B
$6.97K ﹤0.01%
150
– –
PLTR icon
412
Palantir
PLTR
$448B
$6.84K ﹤0.01%
270
– –
IBIT icon
413
iShares Bitcoin Trust
IBIT
$58.6B
$6.83K ﹤0.01%
+200
New +$7.47K
GCV
414
Gabelli Convertible and Income Securities Fund
GCV
$92.5M
$6.82K ﹤0.01%
1,863
+61
+3% +$220
GDV icon
415
Gabelli Dividend & Income Trust
GDV
$2.65B
$6.81K ﹤0.01%
300
– –
XYL icon
416
Xylem
XYL
$26B
$6.78K ﹤0.01%
50
– –
TECB icon
417
iShares US Tech Breakthrough Multisector ETF
TECB
$503M
$6.76K ﹤0.01%
134
– –
TMO icon
418
Thermo Fisher Scientific
TMO
$230B
$6.64K ﹤0.01%
12
– –
DG icon
419
Dollar General
DG
$27.1B
$6.61K ﹤0.01%
50
– –
PKG icon
420
Packaging Corp of America
PKG
$21.4B
$6.53K ﹤0.01%
36
– –
DGICA icon
421
Donegal Group Class A
DGICA
$714M
$6.44K ﹤0.01%
500
-409
-45% -$5.43K
TEL icon
422
TE Connectivity
TEL
$58.7B
$6.32K ﹤0.01%
42
– –
ARES icon
423
Ares Management
ARES
$32.1B
$6.26K ﹤0.01%
47
– –
SMMD icon
424
iShares Russell 2500 ETF
SMMD
$3.78B
$6.26K ﹤0.01%
100
– –
SCHH icon
425
Schwab US REIT ETF
SCHH
$11.3B
$6.23K ﹤0.01%
312
+20
+7% +$390
15 16
17
18 19

Similar funds

EDRIA
Edmonds Duncan Registered Investment Advisors Lawrence, Kansas $457M AUM 23% 1-Year Est. Return
SFP
Sweet Financial Partners Fairmont, Minnesota $462M AUM 26.73% 1-Year Est. Return
AC
Albar Capital London, United Kingdom $445M AUM 55.79% 1-Year Est. Return
NIC
Northwest Investment Counselors Lake Oswego, Oregon $442M AUM 29.9% 1-Year Est. Return
WCA
Waypoint Capital Advisors Minneapolis, Minnesota $470M AUM 32.8% 1-Year Est. Return
KC
Kingfisher Capital Charlotte, North Carolina $437M AUM 41.72% 1-Year Est. Return
SIGI
Susquehanna International Group (Ireland) Dublin, Ireland $472M AUM 25.62% 1-Year Est. Return
FPFS
First Personal Financial Services Charlotte, North Carolina $473M AUM 28.33% 1-Year Est. Return

M&R Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, M&R Capital Management held 559 positions worth $419M, up 2.7% from $408M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 4.1%. M&R Capital Management opened 11 new positions and exited 12, leaving the 559-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • M&R Capital Management's largest Q2 2024 buy was KeyCorp: 11,973 shares worth $170K.
  • M&R Capital Management added most to AstraZeneca in Q2 2024, an estimated $8.37M increase.
  • M&R Capital Management's biggest Q2 2024 reduction was CVS Health, cutting an estimated $8.98M.
  • M&R Capital Management fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $42.7K.
  • M&R Capital Management's ten largest holdings make up 48% of its $419M portfolio in Q2 2024.
  • M&R Capital Management opened 11 new positions and closed 12 in Q2 2024.
  • M&R Capital Management's portfolio value rose 2.7% quarter-over-quarter to $419M.

Based on M&R Capital Management's 13F filing for Q2 2024, filed 2 Jul 2024.